A Dual-Site Inhibitor of CBP/p300 KIX is a Selective and Effective Modulator of Myb
S. T. Joy, M. J. Henley, S. N. De Salle, M. J. Beyersdorf, I. W. Vock, A. J. L. Huldin, A. Mapp
This paper develops a dual-site inhibitor, MybLL-tide, that selectively targets the CBP/p300 KIX domain, inhibiting Myb-dependent gene expression in AML cells.
bioRxiv · Apr 28, 2021Biochemistry